ibutilide has been researched along with Auricular Fibrillation in 136 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 34 (25.00) | 18.2507 |
| 2000's | 76 (55.88) | 29.6817 |
| 2010's | 22 (16.18) | 24.3611 |
| 2020's | 4 (2.94) | 2.80 |
| Authors | Studies |
|---|---|
| Cacioppo, F; Domanovits, H; Gupta, S; Herkner, H; Laggner, AN; Lutnik, M; Niederdoeckl, J; Oppenauer, J; Roth, D; Schnaubelt, S; Schuetz, N; Schwameis, M; Simon, A; Spiel, AO | 1 |
| Corp Dit Genti, V; Crijns, HJ; Koren, A; Kowey, PR; Naccarelli, GV; Reiffel, JA; Thind, M; Wieloch, M | 1 |
| Dasgupta, S; Dave, I; Fischbach, P; Whitehill, R | 1 |
| He, SN; Li, XX; Liu, XP; Shi, L; Tian, Y; Wang, YJ; Xie, BQ; Yang, XC; Zeng, LJ | 1 |
| Cai, S; Ding, W; Wang, M; Zhao, Q | 1 |
| Bhargava, K | 1 |
| Ballard, DW; Lugovskaya, N; Nagam, MR; Reed, ME; Rome, AM; Stevenson, MD; Vinson, DR; Warton, EM | 1 |
| Li, J; Li, K; Liu, M; Liu, X; Yang, X; Zhong, J; Zuo, K | 1 |
| Ma, C; Xiang, M; Yang, Y; Yu, Z; Zhang, S | 1 |
| Agarwal, R; Bickford, CL; Durand, JB; Lenihan, DJ; Urbauer, DL | 1 |
| Biviano, AB; Ciaccio, EJ; Gabelman, T; Garan, H; Whang, W | 1 |
| Hirayama, A; Kofune, M; Kogawa, R; Mano, H; Nakai, T; Ohkubo, K; Okumura, Y; Sasaki, N; Sonoda, K; Watanabe, I | 1 |
| Hirayama, A; Kogawa, R; Nakai, T; Ohkubo, K; Okumura, Y; Sasaki, N; Sonoda, K; Takahashi, K; Watanabe, I | 1 |
| Narayan, SM; Rappel, WJ; Vidmar, D | 1 |
| Aryana, A; Barrett, CD; d'Avila, A; Dukkipati, SR; Heist, EK; Kim, YH; Mangrum, JM; Michaud, GF; Parides, MK; Reddy, VY; Singh, SM; Thorpe, KE | 1 |
| Shah, D | 1 |
| Domanovits, H; Herkner, H; Laggner, AN; Niederdoeckl, J; Schuetz, N; Simon, A; Skyllouriotis, E; Spiel, AO; Weiser, C | 1 |
| Bikias, A; Delithanasis, I; Fragakis, N; Katsaris, G; Konstantinidou, M; Kozirakis, M; Liakopoulos, N | 1 |
| Gopinathannair, R; Olshansky, B | 1 |
| Hofmann, R; Hönig, S; Kammler, J; Kypta, A; Leisch, F; Schmitt, B; Steinwender, C | 1 |
| Benza, RL; Bourge, RC; Franco, V; Kirklin, JK; McGiffin, DC; Pamboukian, SV; Rayburn, BK; Smallfield, M; Tallaj, JA | 1 |
| D'Avila, A; Dukkipati, SR; Houghtaling, C; Kim, SJ; Reddy, VY; Singh, SM | 1 |
| Antonatos, D; Babalis, D; Christou, A; Kafkas, N; Katsanos, S; Nikolaou, N; Patsilinakos, S; Spanodimos, S | 1 |
| Globits, S; Hirschl, MM; Wollmann, C | 1 |
| Naccarelli, GV; Samii, SM | 1 |
| Fang, PH; Hou, Y; Hu, JQ; Li, XF; Liu, J; Zhang, S | 1 |
| Aryana, A; Barrett, CD; Beras-Jovine, MR; Callans, DJ; D'Avila, A; Dukkipati, SR; Kim, YH; Mangrum, JM; Michaud, GF; Reddy, VY; Singh, SM | 1 |
| Gao, LJ; Li, YW; Lin, YB; Tian, XC; Wang, YM; Xia, YL; Yang, YZ; Zhang, SL | 1 |
| Guo, JH; Han, R; Li, XY; Ma, XL; Sun, JL; Wang, CY | 1 |
| Heidland, UE; Heintzen, MP; Hennersdorf, MG; Perings, C; Perings, SM; Strauer, BE; Zühlke, C | 1 |
| Kobayashi, Y | 1 |
| Chugh, A; Greenstein, R; Hassan, S; Knight, BP; Lai, SW; Morady, F; Oral, H; Ozaydin, M; Pelosi, F; Scharf, C; Strickberger, SA; Tada, H | 1 |
| Knight, BP; Morady, F; Oral, H; Ozaydin, M; Pelosi, F; Sticherling, C; Strickberger, SA; Tada, H | 1 |
| Bedi, A; Cheriparambil, K; Das, MK; Kassotis, J; Makan, M; Reddy, CV; Saul, B | 1 |
| Calò, L; Pignalberi, C; Ricci, R; Santini, M | 1 |
| Caron, MF; Kalus, JS; Kluger, J; Ritvo, A; Tsikouris, JP; White, CM | 1 |
| Abiose, A; Abordo, M; Berns, E; Dalamagas, H; Jaagosild, P; Lippman, N; Madhusoodanan, KP; Silverman, D; Soucier, R; Therrien, M | 1 |
| Kao, W; Kowey, PR; Winkel, E; Yan, GX | 1 |
| Bernard, EO; Candinas, R; Germann, R; Scharf, C; Schmid, ER; Schmidlin, D | 1 |
| Calò, L; Pignalberi, C; Ricci, R; Santini, L; Santini, M | 1 |
| Chung, JO; Kalus, JS; Kenyon, KW; Kluger, J; Spencer, AP; Tsikouris, JP; White, CM; Ziska, M | 1 |
| Guttigoli, A; Iwai, S; Lerman, BB; Markowitz, SM; Mittal, S; Stein, KM | 1 |
| Batra, R; Efremidis, M; Ekonomou, D; Evagelou, D; Filippatos, G; Kardara, D; Kardaras, F; Manolatos, D; Sideris, A; Xidonas, S | 1 |
| Gowda, RM; Khan, IA; Punukollu, G; Sacchi, TJ; Vasavada, BC; Wilbur, SL | 1 |
| Anastasopoulos, A; Dilaveris, P; Giaouris, P; Stefanadis, C; Theoharis, A; Tzannetis, G; Zumerle, B | 1 |
| Khan, IA | 1 |
| Aicher, F; Bachleitner, T; Eisserer, G; Gatterer, E; Grander, W; Heinze, G; Kühn, P; Lang, W; Niemeth, C; Reisinger, J; Siostrzonek, P; Vanicek, T | 1 |
| Chiladakis, JA; Kalogeropoulos, A; Manolis, AS; Patsouras, N | 1 |
| Bonso, A; Glatter, KA; Hongo, RH; Raviele, A; Rossillo, A; Scheinman, MM; Themistoclakis, S; Yang, Y | 1 |
| Pürerfellner, H | 1 |
| Borchard, R; Brandts, B; Dirkmann, D; Meine, M; Prull, MW; Trappe, HJ; Van Bracht, M; Wickenbrock, I | 1 |
| Chung, JO; Coleman, CI; Kalus, JS; Kenyon, KW; Kluger, J; Reddy, P; Spencer, AP; Tsikouris, JP; White, CM; Ziska, M | 1 |
| Allessie, MA; Blaauw, Y; Gögelein, H; Schotten, U; Tieleman, RG; van Hunnik, A | 1 |
| Gorski, JC; Mehra, R; Ujhelyi, M; Vereckei, A; Zipes, DP | 1 |
| Bertel, O; Naegeli, B; Straumann, E | 1 |
| Delle Karth, G; Geppert, A; Gwechenberger, M; Haumer, M; Heinz, G; Meyer, B; Schillinger, M; Siostrzonek, P | 1 |
| Ammash, NM; Ballman, KV; Chandrasekaran, K; Friedman, PA; Gersh, BJ; Gurevitz, OT; Hammill, SC; Malouf, JF; Rosales, AG; White, RD | 1 |
| Doggrell, SA; Hancox, JC | 1 |
| Fang, Q; Ge, JB; Guo, JH; Guo, JX; Han, SM; Sun, YM; Wan, Z; Zhang, HC; Zheng, YA; Zhu, WQ | 1 |
| Allessie, M; Blaauw, Y; Duytschaever, M | 1 |
| Dilaveris, P; Gialafos, E; Giannopoulos, G; Stefanadis, C; Synetos, A | 1 |
| Chen, PS; Chou, CC; Hayashi, H; Nihei, M; Tan, AY; Zhou, S | 1 |
| Draganigos, A; Goudevenos, JA; Katsouras, CS; Kolettis, TM; Kolios, P; Korantzopoulos, P; Leontaridis, I; Naka, KK; Papathanasiou, A | 1 |
| Fragakis, N; Katsaris, G; Kozirakis, M; Maligkos, G; Papadopoulos, N; Papanastasiou, S; Tsaritsaniotis, E | 1 |
| Cummins, FH; Fahy, GJ; Ryan, DT | 1 |
| Scharf, C | 1 |
| Borchard, R; Pott, L; Prull, MW; Trappe, HJ; van Bracht, M; Wickenbrock, I | 1 |
| Guo, JH; Li, XB; Xn, Y; Zhang, HCh; Zhang, N; Zhang, P | 1 |
| Arnar, DO; Henriksdottir, A; Viktorsdottir, O | 1 |
| Becuzzi, L; Corbucci, G; Mazzocca, G; Venturini, E | 1 |
| McPherson, CA; Mountantonakis, SE; Moutzouris, DA; Papaioannou, GN; Tiu, RV | 1 |
| Chaveles, JI; Dagadaki, OK; Kafkas, NV; Kelesidis, KM; Mertzanos, GA; Papageorgiou, KI; Patsilinakos, SP | 1 |
| Chen, PS; Chou, CC; Fishbein, MC; Hwang, C; Karagueuzian, HS; Lin, SF; Tan, AY; Zhou, S | 1 |
| Bonios, M; Exarchos, P; Kogias, J; Melexopoulou, C; Sideris, S; Tsatiris, K | 1 |
| Fahy, GJ; Kiernan, T; Kocka, V; Kockova, R | 1 |
| Allessie, MA; Blaauw, Y; Neuberger, HR; Schotten, U; van Hunnik, A | 1 |
| Balaji, S; Hoyer, AW | 1 |
| Coleman, CI; Kluger, J; Tercius, AJ; White, CM | 1 |
| Carey, MG; Pelter, MM | 1 |
| Elnabtity, M; Fromm, BS; Lavine, SJ; Lehmann, MH; Meissner, MD; Munir, A; Nabih, MA; Prcevski, P; Steinman, RT | 1 |
| Ellenbogen, KA; Meissner, MC; Perry, KT; Sager, PT; Stambler, BS; Vanderlugt, JT; Wakefield, LK; Wesley, RC; Wood, MA; Zoble, RG | 1 |
| Roden, DM | 1 |
| Ellenbogen, KA; Perry, KT; Stambler, BS; VanderLugt, JT; Wakefield, LK; Wood, MA | 1 |
| Pratt, CM; Waldo, AL | 1 |
| Gibson, JK; Lee, KS; Naccarelli, GV; VanderLugt, J | 1 |
| Clemo, HF; Ellenbogen, KA; Stambler, BS; VanderLugt, JT; Wood, MA | 1 |
| Kowey, PR; Luderer, JR; VanderLugt, JT | 1 |
| DiMarco, JP; Jung, F | 1 |
| Kayser, SR | 1 |
| Foster, RH; Markham, A; Wilde, MI | 1 |
| Conti, CR | 1 |
| Ellenbogen, KA; Stambler, BS; Wood, MA | 1 |
| Strimike, CL; Wojcik, JM | 1 |
| Asher, CR; Chung, MK; Ellenbogen, KA; Wood, MA | 1 |
| Murray, KT | 1 |
| Davis, J; Labhasetwar, V; Levy, RJ; Strickberger, SA; Underwood, T | 1 |
| Carberry, PA; Dunn, GH; Kowey, PR; Lewis, WR; Perry, KT; Stambler, B; Vanderlugt, JT; Volgman, AS | 1 |
| Camm, AJ; Obel, OA | 1 |
| Bollmann, A; DeLurgio, DB; Kanuru, NK; Langberg, JJ; McTeague, KK; Walter, PF | 1 |
| Abi-Mansour, P; Carberry, PA; Dunn, GH; Henthorn, RW; McCowan, RJ; Perry, KT | 1 |
| Berrier, KL; Khoury, DS; Sun, H; Velipasaoglu, EO | 1 |
| Assar, MD; Khoury, DS; Sun, H | 1 |
| Howard, PA | 1 |
| Golitsyn, SR; Harry, JD; Perry, KT; Ruda, MY; Stangl, K; Steinbeck, G; Touboul, P; Van Wijk, LV; Vos, MA; Wellens, HJ | 1 |
| Amin, NB; Borzak, S; Housholder, S; Tisdale, JE | 1 |
| Califf, RM | 1 |
| Bala, MV; Calingaert, B; VanderLugt, JT; Zarkin, GA | 1 |
| Goyal, R; Knight, BP; Michaud, GF; Morady, F; Oral, H; Souza, JJ; Strickberger, SA | 1 |
| Podrid, PJ | 1 |
| Ahern, T; Denker, S; Kowey, PR; Mattioni, T; Perry, KT; Torchiana, D; VanderLugt, JT; Wakefield, LK | 1 |
| Mirzaietehrane, M; Sedighi, A; Varriale, P | 1 |
| Hong, RA; Kaufman, LJ; Kofalvi, AE; Low, LL; Moreno-Cabral, CE | 1 |
| Barrington, W; Beheiry, S; Cooper, P; Easley, A; Leonelli, F; Li, H; Natale, A; Tomassoni, G; Windle, J | 1 |
| Guenette, AJ; Kaliebe, J; Murdock, DK; Olson, K; Schumock, GT | 1 |
| Sedighi, A; Varriale, P | 1 |
| Langberg, JJ; Schwartz, RA | 1 |
| Dhruva, NN; Sobel, RM | 1 |
| Accardi, R; Cammilli, L; Catanzariti, D; Cozzi, F; Spagnolli, W; Vergara, G | 1 |
| Brunner, M; Domanovits, H; Janata, K; Laggner, AN; Nikfardjam, M; Schillinger, M; Thoennissen, J | 1 |
| Trohman, RG | 1 |
| Afshar, H; Khoshnevis, R; Massumi, A; Rasekh, A; Vaughn, WK; Zaqqa, M | 1 |
| Chow, MS; Dunn, AB; Kluger, J; Reddy, P; White, CM | 1 |
| Baker, RL; Chough, SP; Fendrick, AM; Kim, MH; Knight, BP; Michaud, GF; Morady, F; Oral, H; Pelosi, F; Sticherling, C; Strickberger, SA; Wasmer, K | 1 |
| Blitzer, M; Reiffel, JA | 1 |
| Rogers, KC; Wolfe, DA | 1 |
| Chatterjee, K; Cheng, J; Glatter, K; Kayser, S; Modin, G; Scheinman, MM; Yang, Y | 1 |
| Anaclerio, M; Forleo, C; Grimaldi, M; Iacoviello, M; Luzzi, G; Pitzalis, MV; Rizzon, P | 1 |
| Mehra, R; Vereckei, A; Warman, E; Zipes, DP | 1 |
| Donaldson, AR; Taylor, CT | 1 |
| Conti, CR; Eversole, A; Hancock, W; Johns, T; Lopez, LM | 1 |
| Conway, DS; Lip, GY | 1 |
| Dorostkar, PC; Glatter, KA; Keung, E; Lee, RJ; Modin, G; Scheinman, MM; Van Hare, GF; Yang, Y | 1 |
| Brown-Mahoney, C; Ellenbogen, KA; Gilligan, DM; Nematzadeh, F; Stambler, BS; Wood, MA | 1 |
| Bares, AC; Hsu, W; Knight, BP; Morady, F; Oral, H; Pelosi, F; Sticherling, C; Strickberger, SA; Tada, H | 1 |
| Bianconi, L; Castro, A; Santini, M | 1 |
26 review(s) available for ibutilide and Auricular Fibrillation
| Article | Year |
|---|---|
Role of Ibutilide in Atrial Fibrillation.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Sulfonamides | 2016 |
[Current strategies of pharmacological and non-pharmacological treatment in atrial fibrillation and atrial flutter].
Topics: Atrial Fibrillation; Atrial Flutter; Body Surface Potential Mapping; Catheter Ablation; Clinical Trials as Topic; Electrophysiology; Humans; Hydantoins; Imidazoles; Imidazolidines; Pacemaker, Artificial; Piperazines; Sulfonamides | 2002 |
Hybrid therapy of atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Catheter Ablation; Combined Modality Therapy; Electric Countershock; Humans; Sulfonamides | 2002 |
Pharmacologic and nonpharmacologic options to maintain sinus rhythm: guideline-based and new approaches.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Catheter Ablation; Flecainide; Heart Rate; Humans; Phenethylamines; Practice Guidelines as Topic; Propafenone; Quinidine; Stroke; Sulfonamides; Ventricular Dysfunction, Left | 2003 |
An update on electrical cardioversion of atrial fibrillation.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Humans; Sulfonamides; Treatment Outcome | 2003 |
Female preponderance in ibutilide-induced torsade de pointes.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Incidence; Male; Sex Distribution; Sulfonamides; Torsades de Pointes | 2004 |
Recent developments in cardiovascular drug therapy: treatment of atrial arrhythmias with new class III drugs and beyond.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Electric Countershock; Electrophysiology; Humans; Hydantoins; Imidazolidines; Pacemaker, Artificial; Phenethylamines; Piperazines; Sulfonamides | 2004 |
Ibutilide--recent molecular insights and accumulating evidence for use in atrial flutter and fibrillation.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Clinical Trials as Topic; Humans; Sulfonamides | 2005 |
[Atrial flutter and fibrillation].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Calcium Channel Blockers; Catheter Ablation; Clinical Trials as Topic; Disopyramide; Electric Countershock; Electrocardiography; Emergencies; Flecainide; Heart Rate; Humans; Middle Aged; Pacemaker, Artificial; Propafenone; Quinidine; Recurrence; Sotalol; Sulfonamides; Treatment Outcome; Vasodilator Agents | 2005 |
The mechanisms of atrial fibrillation.
Topics: Aging; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Biological Clocks; Electrophysiologic Techniques, Cardiac; Humans; Ligaments; Procainamide; Pulmonary Veins; Sulfonamides; Vena Cava, Superior | 2006 |
Electrophysiology and pharmacology of ibutilide.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electrophysiology; Half-Life; Heart Conduction System; Humans; Sulfonamides | 1996 |
Efficacy of ibutilide for termination of atrial fibrillation and flutter.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Controlled Clinical Trials as Topic; Electrocardiography; Humans; Sulfonamides | 1996 |
Safety and risk/benefit analysis of ibutilide for acute conversion of atrial fibrillation/flutter.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Blood Pressure; Clinical Trials as Topic; Electric Countershock; Electrocardiography; Humans; Risk Factors; Safety; Sulfonamides | 1996 |
Antiarrhythmic drug therapy in the treatment of atrial fibrillation.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Electrophysiology; Flecainide; Humans; Ion Channels; Quinidine; Sotalol; Sulfonamides | 1996 |
Ibutilide. A review of its pharmacological properties and clinical potential in the acute management of atrial flutter and fibrillation.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Humans; Sulfonamides | 1997 |
Stopping atrial fibrillation with ibutilide.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Male; Sulfonamides | 1998 |
Postoperative atrial fibrillation.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Atrial Fibrillation; Cerebrovascular Disorders; Coronary Artery Bypass; Costs and Cost Analysis; Digoxin; Heart Rate; Humans; Postoperative Complications; Risk Factors; Sulfonamides | 1997 |
Ibutilide.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Humans; Sulfonamides | 1998 |
The use of drugs for cardioversion of recent onset atrial fibrillation and flutter. Focus on ibutilide.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electric Countershock; Humans; Sulfonamides; Treatment Outcome | 1998 |
Ibutilide: an antiarrhythmic agent for the treatment of atrial fibrillation or flutter.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Clinical Trials as Topic; Humans; MEDLINE; Sulfonamides | 1999 |
Cardioversion of atrial fibrillation with ibutilide in an orthotopic heart transplant patient.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Combined Modality Therapy; Electric Countershock; Female; Heart Transplantation; Humans; Infusions, Intravenous; Middle Aged; Postoperative Complications; Sulfonamides | 1999 |
Supraventricular tachycardia: implications for the intensivist.
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electrocardiography; Electrophysiologic Techniques, Cardiac; Humans; Sulfonamides; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Supraventricular; Verapamil; Wolff-Parkinson-White Syndrome | 2000 |
Ibutilide: a class III rapidly acting antidysrhythmic for atrial fibrillation or atrial flutter.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Humans; Injections, Intravenous; Patient Selection; Sulfonamides; Time Factors | 2001 |
New antiarrhythmic agents for atrial fibrillation.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Hydantoins; Imidazoles; Imidazolidines; Lidocaine; Phenethylamines; Piperazines; Sulfonamides | 2001 |
Clinical and electrophysiologic effects of calcium channel blockers in patients receiving ibutilide.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Calcium Channel Blockers; Drug Interactions; Electrocardiography; Female; Humans; Male; Polypharmacy; Retrospective Studies; Sulfonamides; Tachycardia, Ventricular | 2002 |
New antiarrhythmic drugs for the treatment of atrial fibrillation.
Topics: Aminobenzoates; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bridged Bicyclo Compounds, Heterocyclic; Cyclopropanes; Dronedarone; Humans; Hydantoins; Imidazoles; Imidazolidines; Phenethylamines; Piperazines; Sotalol; Sulfonamides | 2002 |
39 trial(s) available for ibutilide and Auricular Fibrillation
| Article | Year |
|---|---|
Comparison of Direct Current Synchronized Cardioversion to Ibutilide-Guided Catheter Ablation for Long-Term Sinus Rhythm Maintenance After Isolated Pulmonary Vein Isolation of Persistent Atrial Fibrillation.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Electric Countershock; Electrophysiologic Techniques, Cardiac; Female; Follow-Up Studies; Heart Atria; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; Pulmonary Veins; Recurrence; Retrospective Studies; Sulfonamides; Time Factors; Treatment Outcome | 2017 |
[Efficacy and safety of ibutilide for conversion of atrial fibrillation/flutter].
Topics: Adolescent; Adult; Aged; Atrial Fibrillation; Atrial Flutter; Female; Humans; Male; Middle Aged; Propafenone; Sulfonamides; Treatment Outcome; Young Adult | 2013 |
Ibutilide increases the variability and complexity of atrial fibrillation electrograms: antiarrhythmic insights using signal analyses.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Diagnosis, Computer-Assisted; Electrocardiography; Female; Heart Conduction System; Heart Rate; Humans; Male; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Signal Processing, Computer-Assisted; Sulfonamides; Treatment Outcome; Young Adult | 2013 |
The modified stepwise ablation guided by low-dose ibutilide in chronic atrial fibrillation trial (The MAGIC-AF Study).
Topics: Atrial Fibrillation; Catheter Ablation; Chronic Disease; Electrophysiologic Techniques, Cardiac; Humans; Pulmonary Veins; Sulfonamides; Treatment Outcome | 2016 |
Vernakalant is superior to ibutilide for achieving sinus rhythm in patients with recent-onset atrial fibrillation: a randomized controlled trial at the emergency department.
Topics: Adult; Aged; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Emergency Service, Hospital; Female; Humans; Male; Middle Aged; Pyrrolidines; Sulfonamides; Time Factors; Treatment Outcome | 2017 |
Acute beta-adrenoceptor blockade improves efficacy of ibutilide in conversion of atrial fibrillation with a rapid ventricular rate.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Synergism; Female; Humans; Male; Middle Aged; Propanolamines; Sulfonamides; Treatment Outcome; Ventricular Fibrillation | 2009 |
Pre-injection of magnesium sulfate enhances the efficacy of ibutilide for the conversion of typical but not of atypical persistent atrial flutter.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Drug Synergism; Electrocardiography; Female; Heart Conduction System; Humans; Injections, Intravenous; Magnesium Sulfate; Male; Middle Aged; Placebo Effect; Prospective Studies; Sulfonamides; Treatment Outcome | 2010 |
Effect of high doses of magnesium on converting ibutilide to a safe and more effective agent.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cohort Studies; Drug Therapy, Combination; Female; Humans; Magnesium Sulfate; Male; Middle Aged; Sulfonamides; Torsades de Pointes; Treatment Outcome | 2010 |
The Modified Ablation Guided by Ibutilide Use in Chronic Atrial Fibrillation (MAGIC-AF) Study: clinical background and study design.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Canada; Catheter Ablation; Chronic Disease; Combined Modality Therapy; Double-Blind Method; Drug Administration Schedule; Echocardiography; Electrocardiography, Ambulatory; Electrophysiologic Techniques, Cardiac; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Predictive Value of Tests; Prospective Studies; Pulmonary Veins; Recurrence; Republic of Korea; Research Design; Sulfonamides; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; United States | 2012 |
[Efficacy of ibutilide for cardioversion of persistent atrial fibrillation during radiofrequency ablation].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Female; Humans; Male; Middle Aged; Sulfonamides | 2011 |
Comparison of amiodarone versus ibutilide for the prevention of immediate recurrences of atrial fibrillation during pulmonary vein isolation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Cross-Over Studies; Electrophysiologic Techniques, Cardiac; Female; Humans; Male; Middle Aged; Prevalence; Prospective Studies; Pulmonary Veins; Recurrence; Sulfonamides; Time Factors; Treatment Outcome | 2002 |
Comparison of verapamil and ibutilide for the suppression of immediate recurrences of atrial fibrillation after transthoracic cardioversion.
Topics: Aged; Atrial Fibrillation; Chi-Square Distribution; Electric Countershock; Female; Follow-Up Studies; Humans; Male; Middle Aged; Recurrence; Sulfonamides; Verapamil | 2002 |
Effects of intravenous magnesium sulfate on the QT interval in patients receiving ibutilide.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Double-Blind Method; Electrocardiography; Female; Humans; Infusions, Intravenous; Magnesium Sulfate; Male; Sulfonamides | 2003 |
Propafenone versus ibutilide for post operative atrial fibrillation following cardiac surgery: neither strategy improves outcomes compared to rate control alone (the PIPAF study).
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Female; Humans; Length of Stay; Male; Middle Aged; Postoperative Complications; Propafenone; Prospective Studies; Sulfonamides | 2003 |
Ibutilide versus amiodarone in atrial fibrillation: a double-blinded, randomized study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Blood Pressure; Double-Blind Method; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Male; Middle Aged; Prospective Studies; Sulfonamides | 2003 |
Facilitating internal cardioversion of chronic atrial fibrillation with ibutilide--predictors of atrial defibrillation-threshold decrease.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Female; Humans; Male; Middle Aged; Prognosis; Sulfonamides | 2004 |
Ibutilide-induced alterations in electrocardiographic and spatial vectorcardiographic descriptors of ventricular repolarization.
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Atrial Fibrillation; Female; Heart Rate; Heart Ventricles; Humans; Infusions, Intravenous; Male; Prospective Studies; Sulfonamides; Vectorcardiography | 2004 |
Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cost-Benefit Analysis; Female; Flecainide; Humans; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Single-Blind Method; Sulfonamides | 2004 |
Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
Topics: Administration, Oral; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Drug Administration Schedule; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Propafenone; Prospective Studies; Sulfonamides; Treatment Outcome | 2004 |
Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Drug Administration Schedule; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Female; Flecainide; Heart Conduction System; Humans; Italy; Male; Middle Aged; Propafenone; Prospective Studies; San Francisco; Sulfonamides; Treatment Outcome | 2004 |
Ibutilide for rapid conversion of atrial fibrillation or flutter in a mixed critically ill patient population.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Austria; Critical Care; Female; Humans; Male; Middle Aged; Risk Assessment; Risk Factors; Sulfonamides; Treatment Outcome | 2005 |
[Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].
Topics: Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electrocardiography; Female; Humans; Injections, Intravenous; Male; Middle Aged; Propafenone; Prospective Studies; Single-Blind Method; Sulfonamides; Treatment Outcome | 2005 |
Propafenone added to ibutilide increases conversion rates of persistent atrial fibrillation.
Topics: Administration, Oral; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Propafenone; Sulfonamides; Treatment Outcome | 2006 |
Comparison of intravenous ibutilide vs. propafenone for rapid termination of recent onset atrial fibrillation.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, Drug; Epidemiologic Methods; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Propafenone; Sulfonamides; Treatment Outcome | 2005 |
Is pretreatment with ibutilide useful for atrial fibrillation cardioversion when combined with biphasic shock?
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Electric Countershock; Female; Humans; Male; Middle Aged; Sulfonamides | 2006 |
Ibutilide to expedite ED therapy for recent-onset atrial fibrillation flutter.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Emergency Service, Hospital; Female; Hospitals, Community; Humans; Hypotension; Infusions, Intravenous; Length of Stay; Male; Metoprolol; Prospective Studies; Sulfonamides | 2006 |
Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter.
Topics: Acute Disease; Aged; Aged, 80 and over; Amiodarone; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Probability; Prospective Studies; Recurrence; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Sulfonamides; Treatment Outcome | 2007 |
Intravenous magnesium sulfate enhances the ability of intravenous ibutilide to successfully convert atrial fibrillation or flutter.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cohort Studies; Drug Therapy, Combination; Electrocardiography; Female; Humans; Injections, Intravenous; Magnesium Sulfate; Male; Middle Aged; Sulfonamides; Treatment Outcome | 2007 |
Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Sulfonamides; Tachycardia, Ventricular; Time Factors | 1996 |
Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Forecasting; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Prospective Studies; Sulfonamides; Tachycardia, Ventricular; Treatment Outcome | 1996 |
Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electrophysiology; Female; Humans; Injections, Intravenous; Male; Middle Aged; Procainamide; Sulfonamides; Treatment Outcome | 1997 |
Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Electric Countershock; Female; Humans; Male; Procainamide; Prospective Studies; Sulfonamides; Treatment Outcome | 1998 |
Conversion efficacy and safety of repeated doses of ibutilide in patients with atrial flutter and atrial fibrillation. Study Investigators.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Missouri; Sulfonamides; Treatment Outcome | 1998 |
Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Sotalol; Sulfonamides; Time Factors | 1998 |
The cost-effectiveness of ibutilide versus electrical cardioversion in the conversion of atrial fibrillation and flutter to normal rhythm.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cost-Benefit Analysis; Double-Blind Method; Electric Countershock; Health Resources; Humans; Placebos; Sulfonamides; Technology Assessment, Biomedical | 1997 |
Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cross-Over Studies; Electric Countershock; Electrocardiography; Female; Humans; Male; Middle Aged; Premedication; Secondary Prevention; Sulfonamides; Tachycardia, Ventricular | 1999 |
Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery.
Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cardiac Surgical Procedures; Dose-Response Relationship, Drug; Double-Blind Method; Heart Rate; Humans; Postoperative Complications; Sulfonamides; Tachycardia, Ventricular | 1999 |
Clinical and cost comparison of ibutilide and direct-current cardioversion for atrial fibrillation and flutter.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cost-Benefit Analysis; Electric Countershock; Electrocardiography; Female; Heart Rate; Hospital Costs; Humans; Injections, Intravenous; Male; Medicare; Sulfonamides; Treatment Outcome; United States | 2000 |
Electrophysiological effects of ibutilide in patients with accessory pathways.
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Catheterization; Cardiac Pacing, Artificial; Child; Child, Preschool; Electrocardiography; Electrophysiologic Techniques, Cardiac; Female; Heart Conduction System; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Sulfonamides; Treatment Outcome; Wolff-Parkinson-White Syndrome | 2001 |
71 other study(ies) available for ibutilide and Auricular Fibrillation
| Article | Year |
|---|---|
Cardioversion of Post-Ablation Atrial Tachyarrhythmia with Ibutilide and Amiodarone: A Registry-Based Cohort Study.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cohort Studies; Electric Countershock; Humans; Registries; Sulfonamides; Tachycardia; Treatment Outcome | 2022 |
Dronedarone treatment following cardioversion in patients with atrial fibrillation/flutter: A post hoc analysis of the EURIDIS and ADONIS trials.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Clinical Trials, Phase III as Topic; Dronedarone; Electric Countershock; Europe; Female; Heart Rate; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Recurrence; Retreatment; Risk Assessment; Risk Factors; Sulfonamides; Time Factors; Treatment Outcome; United States | 2020 |
Chemical cardioversion of atrial flutter and fibrillation in the pediatric population with Ibutilide.
Topics: Adolescent; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Child; Child, Preschool; Female; Heart Defects, Congenital; Humans; Infant; Infant, Newborn; Male; Retrospective Studies; Sulfonamides; Young Adult | 2020 |
Identification of circumferential pulmonary vein isolation responders among patients with persistent atrial fibrillation: clinical value of the sequential low-dose ibutilide test.
Topics: Atrial Fibrillation; Catheter Ablation; Humans; Prospective Studies; Pulmonary Veins; Recurrence; Sulfonamides; Treatment Outcome | 2020 |
Ibutilide Effectiveness and Safety in the Cardioversion of Atrial Fibrillation and Flutter in the Community Emergency Department.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Combined Modality Therapy; Electric Countershock; Emergency Service, Hospital; Female; Humans; Male; Middle Aged; Patient Selection; Retrospective Studies; Sulfonamides; Treatment Outcome; Young Adult | 2018 |
Correlation of left atrial wall thickness and atrial remodeling in atrial fibrillation: Study based on low-dose-ibutilide-facilitated catheter ablation.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Remodeling; Catheter Ablation; Contrast Media; Female; Follow-Up Studies; Heart Atria; Humans; Male; Middle Aged; Organ Size; Prospective Studies; Sulfonamides; Tomography, X-Ray Computed; Treatment Outcome | 2019 |
Efficacy and safety of ibutilide for chemical cardioversion of atrial fibrillation and atrial flutter in cancer patients.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electric Countershock; Electrocardiography; Female; Humans; Male; Middle Aged; Neoplasms; Retrospective Studies; Sulfonamides | 2014 |
Rate-dependent electrophysiologic effects of the class III antiarrhythmic drugs nifekalant, amiodarone, and ibutilide on the atrium in patients with persistent atrial fibrillation.
Topics: Action Potentials; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Female; Heart Atria; Heart Conduction System; Humans; Male; Middle Aged; Pyrimidinones; Sulfonamides | 2013 |
Effects of intravenous amiodarone and ibutilide on action potential duration and atrial conduction kinetics in patients with persistent atrial fibrillation.
Topics: Action Potentials; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Heart Atria; Heart Conduction System; Humans; Injections, Intravenous; Male; Middle Aged; Sulfonamides; Treatment Outcome | 2014 |
Phase synchrony reveals organization in human atrial fibrillation.
Topics: Aged; Algorithms; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheters; Computer Simulation; Disease Progression; Electrocardiography; Electrodes; Humans; Membrane Potentials; Middle Aged; Sulfonamides; Tachycardia, Ectopic Atrial; Wavelet Analysis | 2015 |
Does targeting ibutilide-resistant CFAE improve outcomes for catheter ablation of persistent AF?
Topics: Atrial Fibrillation; Catheter Ablation; Humans; Sulfonamides; Treatment Outcome | 2016 |
Ibutilide revisited: stronger and safer than ever.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Sulfonamides; Ventricular Fibrillation | 2009 |
Safety and efficacy of ibutilide in heart transplant recipients.
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Atrioventricular Block; Biopsy; Electrocardiography; Endocardium; Female; Graft Rejection; Heart Transplantation; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardium; Postoperative Complications; Sulfonamides; Tachycardia, Supraventricular; Treatment Outcome | 2009 |
Intraprocedural use of ibutilide to organize and guide ablation of complex fractionated atrial electrograms: preliminary assessment of a modified step-wise approach to ablation of persistent atrial fibrillation.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Cohort Studies; Electrocardiography; Female; Follow-Up Studies; Heart Atria; Humans; Injections, Intravenous; Male; Middle Aged; Preoperative Care; Prospective Studies; Sulfonamides; Treatment Outcome | 2010 |
A 2-year survey of treatment of acute atrial fibrillation in an ED.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Digoxin; Diltiazem; Emergency Service, Hospital; Female; Flecainide; Humans; Male; Middle Aged; Sulfonamides; Time Factors; Treatment Outcome | 2011 |
Atrial fibrillation: AVRO--were the results a surprise?
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Statistics as Topic; Sulfonamides | 2011 |
Single dose of ibutilide for conversion of persistent atrial fibrillation after radiofrequency ablation.
Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Female; Humans; Male; Middle Aged; Sulfonamides; Treatment Outcome | 2011 |
Effects of ibutilide on canine cardiac pacing threshold and on induction rates of atrial fibrillation.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Dogs; Electric Countershock; Heart Atria; Male; Pacemaker, Artificial; Pulmonary Veins; Sulfonamides | 2012 |
Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone has failed.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Critical Care; Electric Countershock; Electrocardiography; Germany; Humans; Intensive Care Units; Middle Aged; Sulfonamides; Treatment Outcome | 2002 |
Cardioversion of atrial fibrillation with ibutilide: when is it most effective?
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Chi-Square Distribution; Echocardiography; Female; Humans; Logistic Models; Male; Risk Factors; Sulfonamides; Time Factors; Treatment Outcome | 2002 |
Effectiveness of ibutilide in cardioversion of persistent atrial fibrillation in patients with dual chamber stimulation.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Female; Humans; Male; Pacemaker, Artificial; Sulfonamides | 2003 |
Impact of prophylactic i.v. magnesium on the efficacy of ibutilide for conversion of atrial fibrillation or flutter.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Chemoprevention; Cohort Studies; Drug Synergism; Female; Humans; Infusions, Intravenous; Magnesium Sulfate; Male; Middle Aged; Retrospective Studies; Sulfonamides; Treatment Outcome | 2003 |
Pharmacological cardioversion of recent onset atrial fibrillation.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Flecainide; Humans; Sulfonamides | 2004 |
[Perspectives and limitations in the treatment of vagus-induced atrial fibrillation. Insights from cellular pharmacology].
Topics: Adult; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Cells, Cultured; Culture Media; Heart Atria; Humans; Membrane Potentials; Phenethylamines; Potassium Channel Blockers; Rats; Sotalol; Sulfonamides; Time Factors; Vagus Nerve | 2004 |
Cost effectiveness of ibutilide with prophylactic magnesium in the treatment of atrial fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Hospitalization; Humans; Magnesium; Male; Middle Aged; Retrospective Studies; Sulfonamides; United States | 2004 |
"Early" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Delayed Rectifier Potassium Channels; Drug Evaluation, Preclinical; Electric Countershock; Female; Goats; Heart Atria; Heart Conduction System; Infusions, Intravenous; Ion Transport; Neural Conduction; Phenethylamines; Potassium; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Sulfonamides | 2004 |
Intrapericardial ibutilide administration fails to terminate pacing-induced sustained atrial fibrillation in dogs.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Electrophysiologic Techniques, Cardiac; Female; Heart Atria; Instillation, Drug; Male; Pericardium; Sulfonamides; Time Factors; Treatment Failure | 2004 |
Ibutilide (Corvert): suspected association with torsades de pointes.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Fatal Outcome; Humans; Male; Middle Aged; Sulfonamides; Torsades de Pointes | 2004 |
Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Combined Modality Therapy; Electric Countershock; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Retrospective Studies; Sulfonamides; Treatment Failure; Treatment Outcome | 2005 |
Comparative efficacy of monophasic and biphasic waveforms for transthoracic cardioversion of atrial fibrillation and atrial flutter.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Atrial Flutter; Combined Modality Therapy; Electric Countershock; Female; Humans; Male; Premedication; Sulfonamides | 2005 |
Consequences of atrial electrical remodeling for the anti-arrhythmic action of class IC and class III drugs.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function; Electric Countershock; Electrophysiology; Flecainide; Goats; Models, Animal; Random Allocation; Refractory Period, Electrophysiological; Sotalol; Sulfonamides; Treatment Failure; Ventricular Remodeling | 2005 |
Conversion of recent-onset atrial fibrillation or flutter with amiodarone after ibutilide has failed: a rapid, efficient, and safe algorithm.
Topics: Aged; Algorithms; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Chi-Square Distribution; Electrocardiography; Female; Humans; Male; Pilot Projects; Sulfonamides; Treatment Outcome | 2005 |
High-density mapping of pulmonary veins and left atrium during ibutilide administration in a canine model of sustained atrial fibrillation.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Body Surface Potential Mapping; Diagnosis, Computer-Assisted; Disease Models, Animal; Dogs; Female; Heart Atria; Heart Conduction System; Pulmonary Veins; Sulfonamides; Treatment Outcome | 2005 |
Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone.
Topics: Adult; Aged; Amiodarone; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Chi-Square Distribution; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Propafenone; Prospective Studies; Sulfonamides; Treatment Outcome | 2005 |
Rapid cardioversion of new onset atrial fibrillation with ibutilide in the emergency department.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Emergency Service, Hospital; Female; Humans; Middle Aged; Sulfonamides | 2005 |
[Inhibition of the muscarinic potassium current by KB130015, a new antiarrhythmic agent to treat atrial fibrillation].
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzofurans; Cells, Cultured; Guinea Pigs; Heart Atria; Potassium Channels; Receptors, Muscarinic; Sulfonamides | 2005 |
Ibutilide for treatment of atrial fibrillation in the emergency department.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Case-Control Studies; Emergency Service, Hospital; Female; Humans; Male; Middle Aged; Retrospective Studies; Sulfonamides | 2006 |
The role of amiodarone in recent-onset atrial fibrillation after ibutilide has failed to restore sinus rhythm.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Male; Sulfonamides; Treatment Outcome | 2007 |
Ibutilide-induced cardioversion of atrial fibrillation during pregnancy.
Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Sulfonamides; Treatment Outcome | 2007 |
Cardioversion of persistent atrial fibrillation by a combination of atrial specific and non-specific class III drugs in the goat.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Biphenyl Compounds; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Female; Goats; Phenethylamines; Sulfonamides | 2007 |
The safety and efficacy of ibutilide in children and in patients with congenital heart disease.
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Child; Child, Preschool; Female; Heart Defects, Congenital; Humans; Infant; Male; Pacemaker, Artificial; Sulfonamides; Treatment Outcome | 2007 |
Rapid ventricular response.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Bundle-Branch Block; Coronary Artery Bypass; Electrocardiography; Female; Humans; Nausea; Nitroglycerin; Sulfonamides; Vasodilator Agents | 2008 |
Effect of ibutilide, a new class III agent, on sustained atrial fibrillation in a canine model of acute ischemia and myocardial dysfunction induced by microembolization.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Dogs; Infusions, Intravenous; Injections, Intravenous; Myocardial Ischemia; Sulfonamides; Time Factors; Ventricular Function, Left | 1993 |
Ibutilide and the treatment of atrial arrhythmias. A new drug--almost unheralded--is now available to US physicians.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Clinical Trials as Topic; Drug Approval; Humans; Sulfonamides; United States; United States Food and Drug Administration | 1996 |
Introduction: acute treatment of atrial fibrillation and flutter--ibutilide in perspective.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electric Countershock; Humans; Sulfonamides | 1996 |
Ibutilide--a new drug for the rapid termination of atrial fibrillation and atrial flutter.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Humans; Sulfonamides | 1997 |
Atrial fibrillation/flutter: rapid conversion to sinus rhythm with ibutilide.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Heart Rate; Humans; Infusions, Intravenous; Sulfonamides | 1997 |
Prevention of acute inducible atrial flutter in dogs by using an ibutilide-polymer-coated pacing electrode.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Dogs; Drug Delivery Systems; Electrodes; Microscopy, Electron, Scanning; Pacemaker, Artificial; Polymers; Sulfonamides | 1998 |
Frequency analysis of human atrial fibrillation using the surface electrocardiogram and its response to ibutilide.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Female; Humans; Male; Middle Aged; Predictive Value of Tests; Signal Processing, Computer-Assisted; Sulfonamides | 1998 |
Electrophysiological imaging of the right atrium using a noncontact multielectrode cavitary probe: study of normal and abnormal rhythms.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function, Right; Cardiac Pacing, Artificial; Dogs; Electrocardiography; Female; Male; Pacemaker, Artificial; Sulfonamides | 1998 |
Pharmacologic enhancement of atrial electrical defibrillation efficacy: role of ibutilide.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Dogs; Electric Countershock; Electrocardiography; Electrophysiology; Female; Male; Sulfonamides | 1997 |
Sinus bradycardia and multiple episodes of sinus arrest following administration of ibutilide.
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Atrial Fibrillation; Cardiac Pacing, Artificial; Electrocardiography; Female; Heart Arrest; Humans; Sinoatrial Node; Sulfonamides | 1998 |
What to do with acute atrial fibrillation?
Topics: Acute Disease; Anti-Arrhythmia Agents; Atrial Fibrillation; Confounding Factors, Epidemiologic; Humans; Sulfonamides | 1999 |
Redefining the role of antiarrhythmic drugs.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Chemotherapy, Adjuvant; Defibrillators, Implantable; Electric Countershock; Humans; Premedication; Sotalol; Sulfonamides; Tachycardia | 1999 |
Ibutilide for termination of atrial fibrillation in the Wolff-Parkinson-White syndrome.
Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Electrocardiography; Female; Heart Conduction System; Heart Rate; Humans; Infusions, Intravenous; Sulfonamides; Wolff-Parkinson-White Syndrome | 1999 |
Usefulness of ibutilide in facilitating successful external cardioversion of refractory atrial fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, Drug; Electric Countershock; Electrocardiography; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Premedication; Retreatment; Sulfonamides; Treatment Failure | 1999 |
Acute management of atrial fibrillation and atrial flutter in the critical care unit: should it be ibutilide?
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Coronary Care Units; Echocardiography, Transesophageal; Electric Countershock; Electrocardiography; Female; Hemodynamics; Humans; Male; Middle Aged; Secondary Prevention; Sulfonamides; Treatment Outcome | 2000 |
Atrial electrophysiological effects of ibutilide infusion in humans.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Female; Fourier Analysis; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Signal Processing, Computer-Assisted; Sulfonamides; Treatment Outcome | 2000 |
Termination of acute wide QRS complex atrial fibrillation with ibutilide.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Emergency Treatment; Humans; Male; Sulfonamides | 2000 |
Pharmacological atrial defibrillation via temporarily occluded coronary sinus: first clinical experience and implications for an implantable device.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Infusion Pumps, Implantable; Male; Middle Aged; Propafenone; Sulfonamides | 2000 |
Termination of recent-onset atrial fibrillation/flutter in the emergency department: a sequential approach with intravenous ibutilide and external electrical cardioversion.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Combined Modality Therapy; Electric Countershock; Emergency Service, Hospital; Female; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Sulfonamides; Treatment Outcome | 2000 |
Predictors of conversion to sinus rhythm using ibutilide for atrial fibrillation or flutter.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Chi-Square Distribution; Electrocardiography; Female; Heart Rate; Humans; Logistic Models; Male; Multivariate Analysis; Predictive Value of Tests; Retrospective Studies; Risk Factors; Sulfonamides; Time Factors; Treatment Outcome | 2000 |
Efficacy and cost analysis of ibutilide.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Costs and Cost Analysis; Electric Countershock; Female; Humans; Male; Medical Records; Sulfonamides; Torsades de Pointes | 2000 |
Cost analysis of transthoracic cardioversion of atrial fibrillation with and without ibutilide pretreatment.
Topics: Anesthesia, General; Anti-Arrhythmia Agents; Atrial Fibrillation; Cost Savings; Electric Countershock; Health Care Costs; Humans; Outpatients; Sulfonamides | 2000 |
The actions of ibutilide and class Ic drugs on the slow sodium channel: new insights regarding individual pharmacologic effects elucidated through combination therapies.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Therapy, Combination; Electrocardiography; Female; Flecainide; Humans; Male; Middle Aged; Propafenone; Prospective Studies; Sodium Channels; Sulfonamides | 2000 |
Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Stroke Volume; Sulfonamides; Torsades de Pointes | 2001 |
Usefulness of handgrip to improve ibutilide efficacy in organizing atrial electrical activity during atrial fibrillation.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function; Electrocardiography; Female; Hand Strength; Hemodynamics; Humans; Infusions, Intravenous; Isometric Contraction; Male; Middle Aged; Sulfonamides | 2001 |
Comparison of the effects on drug concentrations, electrophysiologic parameters, and termination of atrial fibrillation in dogs when procainamide and ibutilide are delivered into the right atrium versus intravenously.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Circulation; Dogs; Electrophysiology; Female; Femoral Vein; Heart Atria; Hemodynamics; Injections; Injections, Intravenous; Male; Osmolar Concentration; Procainamide; Sulfonamides | 2001 |
Safety and effectiveness of ibutilide in a community hospital.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Female; Hospitals, Community; Humans; Male; Middle Aged; Retrospective Studies; Sulfonamides | 2001 |
Ibutilide: efficacy and safety in atrial fibrillation and atrial flutter in a general cardiology practice.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Safety; Sulfonamides | 2001 |
Effects of verapamil and ibutilide on atrial fibrillation and postfibrillation atrial refractoriness.
Topics: Adult; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Chi-Square Distribution; Female; Heart Atria; Humans; Male; Refractory Period, Electrophysiological; Sulfonamides; Treatment Outcome; Verapamil | 2002 |